Homocysteine: A Heart and Brain Risk Marker — With a Catch

Homocysteine is one of those markers that sounds alarming the moment it's flagged. It's genuinely linked to heart attacks, strokes and even dementia — so a high result feels like something to fix, fast, with a handful of B vitamins. The science of the last twenty years has a more interesting, more honest answer: you can lower the number easily, but lowering it mostly doesn't lower the risk. Understanding why is the key to reading this test well. This is a plain-language, current guide — general education, not a diagnosis; your own results are interpreted by a doctor who knows your history.

What is homocysteine?

Homocysteine is an amino acid — a normal by-product your body makes as it processes another amino acid, methionine, from the protein you eat. Healthy metabolism then recycles it, and that recycling depends on three B vitamins: folate, vitamin B12 and vitamin B6 ¹. When the recycling falters, homocysteine builds up in the blood.

That's the first useful thing the number tells you. Because the clearance pathway runs on B vitamins, a high homocysteine is often a downstream signal of a folate or B12 shortfall — or of reduced kidney function, since the kidneys are the main route for clearing it ¹. In that sense it's less a disease in itself than a clue pointing somewhere else.

Why it's watched: heart, brain and blood vessels

Across large populations, higher homocysteine consistently tracks with more cardiovascular disease, stroke and cognitive decline ². The associations are real and graded — one analysis estimated that each 5 µmol/L higher homocysteine comes with roughly a 20% higher risk of coronary artery disease, and links to Alzheimer's risk have been reported too ². For context on the numbers themselves, a level around 5–15 µmol/L is usually considered normal, with above 15 termed hyperhomocysteinaemia ¹.

So far this sounds like a marker you'd want to drive down. Here's where it gets interesting.

The catch: lowering the number doesn't lower the risk

This is the single most important thing to understand about homocysteine. B vitamins lower it reliably — the major trials cut homocysteine by around 20–27% — and yet those same trials (HOPE-2, NORVIT, VITATOPS and others) did not show fewer heart attacks or deaths ². A pooled analysis across nearly 48,000 people found essentially no reduction in cardiovascular events from homocysteine-lowering ². A 2025 expert review put it plainly: homocysteine "functions better as a cardiovascular risk indicator than as an interventional target" ².

Where there may be some benefit

The picture isn't entirely flat. Two areas keep the marker interesting:

• Stroke. Several analyses suggest a modest (~10%) reduction in stroke with B-vitamin/folate lowering, concentrated in people with low baseline folate and no established heart disease ². It's a smaller, more specific signal than the heart-attack data.
• The brain. In the VITACOG trial, older adults with mild cognitive impairment given high-dose B vitamins lowered homocysteine by about 22% and showed roughly 30% slower brain atrophy than placebo — with the biggest effect in those who started with the highest homocysteine ³. It's a genuinely intriguing result, still actively debated, and not yet proof that this prevents dementia.

Both hint at the same theme: any benefit seems concentrated in people who are deficient to begin with — which fits the idea of homocysteine as a flag for an underlying shortfall.

What about the MTHFR gene?

You may have seen MTHFR gene testing marketed alongside homocysteine. A common genetic variant in the MTHFR gene can nudge homocysteine up — but the official genetics guidance is clear that routine MTHFR testing has minimal clinical utility and shouldn't be ordered as part of standard cardiovascular or clotting work-ups ⁵. For most people it changes nothing about what they'd do. If homocysteine is high, looking at the modifiable causes is far more useful than genotyping.

What a high result should actually prompt

Read as a clue, a raised homocysteine is genuinely useful. It's a reasonable trigger to check the things that drive it: B12 and folate status (see our guide on B12 and folate testing), kidney function, and thyroid — and to look at the overall cardiovascular picture alongside cholesterol and other risk factors ¹. What it shouldn't trigger is a reflexive lifelong B-vitamin regimen taken on the assumption it will protect your heart — because that's the specific thing the trials didn't deliver.

What we see at the clinic

Homocysteine comes up most with the more health-engaged people who pass through Pattaya — often someone who's had it tested elsewhere, seen it flagged, and arrived ready to "fix" it with supplements. Our job is usually to reframe it: to treat it as a flag rather than a target, and to ask why it's up — is folate or B12 low, is kidney function or thyroid involved? Where there's a genuine deficiency, correcting it makes sense on its own merits. Where the homocysteine is mildly raised in someone otherwise well, the honest message is that the number itself is not something we chase, and the energy is better spent on the cardiovascular risks that are proven to matter. We don't diagnose or manage cardiovascular disease from this one line — that's a doctor's job with the full picture.

Common questions

My homocysteine is high — should I take B vitamins to protect my heart? Not on that reasoning alone. B vitamins lower homocysteine reliably, but large trials didn't show fewer heart attacks from doing so ². If you have a genuine B12 or folate deficiency, correcting it is worthwhile in its own right — which is why the first step is finding out why it's high.

Does a high level mean I'll get heart disease or dementia? It's associated with higher risk, but it behaves more like a marker than a direct cause — which is exactly why lowering it doesn't reliably lower outcomes ². It's one input into your risk picture, not a verdict.

Should I get the MTHFR gene test too? Generally no. Official guidance says routine MTHFR testing has minimal clinical utility and isn't recommended for standard cardiovascular or clotting assessments ⁵. It rarely changes what you'd actually do.

Do I even need this test? For most people it isn't a routine screen — MedlinePlus notes homocysteine testing to screen for heart-disease risk isn't recommended for everyone, because lowering it doesn't consistently reduce events ¹. It's more useful in specific situations a doctor will identify.

What makes homocysteine go up? Most often low folate, B12 or B6; also reduced kidney function, an underactive thyroid, genetics, age and smoking ¹. That's why a high value points you toward checking those causes rather than toward the number itself.

Key takeaway

Homocysteine is an amino acid your body recycles with folate, B12 and B6, so a high level is often a clue that one of those — or kidney function — is off ¹. It's linked to heart disease, stroke and cognitive decline, but the defining lesson of the research is the catch: B vitamins lower the number reliably, yet large trials didn't show fewer heart attacks ². There may be a modest stroke and brain-ageing benefit in already-deficient groups ³, and routine MTHFR gene testing isn't recommended ⁵. Treat a raised homocysteine as a flag to investigate — check B12 and folate, kidneys and thyroid — not as a number to chase, and focus your effort on the cardiovascular risks that are proven to count.